North America Commanded the Largest Share of Global Coagulation Analyzers Market in 2014

Date: 2015-08-20

“The global coagulation analyzers market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. Growth in the coagulation analyzers market is driven by factors such as increasing adoption of automated hemostasis instruments by diagnostics laboratories, development of high-throughput hemostasis analyzers, developments in high-sensitivity point-of-care coagulation analyzers, and introduction of technologically advanced hemostasis instruments. However, slow adoption of advanced hemostasis instruments in emerging economies and high cost of hemostasis analyzers are restraining the growth of this market.
In this report, the global coagulation analyzers market has been segmented based on the type of product (clinical laboratory analyzers, point of care testing analyzers) end users (diagnostic laboratories, stand-alone hospitals, research institutes, and other end users), Technology (mechanical, optical, electrochemical, and others), test (PT/INR, APTT, D dimer, Fibrinogen and others). The hemostasis consumables market accounted for the largest share of the global clinical laboratory analyzers market in 2014. Factors such as new product launches, development of high-throughput screening techniques, and increasing adoption of hemostasis automation platforms in laboratories are stimulating the growth of the hemostasis reagents market.
Geographically, North America commanded the largest share of the global coagulation analyzers market in 2014, followed by Europe. The coagulation analyzers market in North America is primarily driven by various factors such as technological advancements, rising incidence/prevalence of patients suffering from blood disorders, and increasing funding to research institutes. However, increasing government pressure to reduce healthcare costs, decreasing reimbursement of laboratory tests, and rising price pressure on market players are restraining the growth of the market in this region. The Asia-Pacific region is poised to grow at the highest CAGR in the next five years, owing to factors such as large patient population, increasing funding/investment towards the development of hemostasis products, and growing focus of both international and domestic players. 

The global coagulation analyzers market is highly competitive, with a large number of big and small market players. As of 2014, the global coagulation analyzers market was dominated by Sysmex Corporation (Japan), Siemens Healthcare (Germany), and Roche Diagnostics (Switzerland). New product launches and expansions are the major strategies adopted by most players to achieve growth in this market.


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample